Literature DB >> 10439995

Development of resistance to chlorhexidine diacetate and cetylpyridinium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility.

U Tattawasart1, J Y Maillard, J R Furr, A D Russell.   

Abstract

Strains of Pseudomonas stutzeri developed stable resistance to chlorhexidine diacetate (CHA) or cetylpyridinium chloride (CPC) when exposed to gradually increasing concentrations of either antibacterial agent. Such strains showed reduced sensitivity to other non-antibiotics, including triclosan, and to some antibiotics, although this varied from strain to strain. Resistant strains were inactivated less readily by CHA or CPC and were less sensitive to sodium dodecyl sulphate. Some CHA-resistant and some CPC-resistant strains were more hydrophobic than the parent strains. Alterations in the cell envelope are likely to be responsible for non-specific changes in sensitivity to several antibacterial agents. Attempts to transfer CHA or CPC resistance by conjugation were unsuccessful. DNA from some CHA- or CPC-resistant strains could transform Ps. stutzeri strain JM 302, a histidine auxotroph, to prototrophy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10439995     DOI: 10.1053/jhin.1999.0591

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  33 in total

Review 1.  Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance.

Authors:  Peter Gilbert; Andrew J McBain
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

2.  Listeria monocytogenes strains selected on ciprofloxacin or the disinfectant benzalkonium chloride exhibit reduced susceptibility to ciprofloxacin, gentamicin, benzalkonium chloride, and other toxic compounds.

Authors:  Mira Rakic-Martinez; Douglas A Drevets; Vikrant Dutta; Vera Katic; Sophia Kathariou
Journal:  Appl Environ Microbiol       Date:  2011-10-14       Impact factor: 4.792

Review 3.  Infections associated with medical devices: pathogenesis, management and prophylaxis.

Authors:  Christof von Eiff; Bernd Jansen; Wolfgang Kohnen; Karsten Becker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Variable Effects of Exposure to Formulated Microbicides on Antibiotic Susceptibility in Firmicutes and Proteobacteria.

Authors:  Sarah Forbes; Christopher G Knight; Nicola L Cowley; Alejandro Amézquita; Peter McClure; Gavin Humphreys; Andrew J McBain
Journal:  Appl Environ Microbiol       Date:  2016-05-31       Impact factor: 4.792

5.  Absence of bacterial resistance to medical-grade manuka honey.

Authors:  R A Cooper; L Jenkins; A F M Henriques; R S Duggan; N F Burton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-13       Impact factor: 3.267

6.  Chlorhexidine-impregnated dressing for prevention of catheter-related bloodstream infection: a meta-analysis*.

Authors:  Nasia Safdar; John C O'Horo; Aiman Ghufran; Allison Bearden; Maria Eugenia Didier; Dan Chateau; Dennis G Maki
Journal:  Crit Care Med       Date:  2014-07       Impact factor: 7.598

Review 7.  Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs.

Authors:  Günter Kampf; Axel Kramer
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  A Descriptive Study of Chlorhexidine as a Disinfectant in Cleft Palate Surgery.

Authors:  Gieljam Johannes Roode; Kurt-Wilhelm Bütow
Journal:  Clin Med Res       Date:  2018-05-03

Review 9.  New technologies to prevent intravascular catheter-related bloodstream infections.

Authors:  L A Mermel
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

10.  Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.

Authors:  Hideaki Maseda; Yumiko Hashida; Rumi Konaka; Akihiro Shirai; Hiroki Kourai
Journal:  Antimicrob Agents Chemother       Date:  2009-09-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.